Signase
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Signase - overview
Location
Houston, TX, US
Primary Industry
Biotechnology
About
Based in US, Signase is a biopharmaceuticals company. It focuses on the development of inhibitors of protein tyrosine kinases.
Current Investors
Pappas Capital, Tripos, BioCapital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.